Related Experiment Video

Updated: May 13, 2025

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

7.6K

Intravesical instillation of chemotherapy before surgery for upper tract urothelial cancer

Edward M Messing1, Kamil Malshy1

  • 1University of Rochester Medical Center, Rochester, NY, USA.

Bladder Cancer (Amsterdam, Netherlands)
|May 9, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

14.7K
Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

15.4K

Related Experiment Videos

Last Updated: May 13, 2025

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

7.6K
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
08:43

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

14.7K
Transurethral Instillation Procedure in Adult Male Mouse
04:01

Transurethral Instillation Procedure in Adult Male Mouse

Published on: November 2, 2017

15.4K

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

152
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
152

Articles linked to this work by shared authors, journal, and citation graph.

Contrasting Reasons for Early Termination Between Industry and Non-Industry-Led Clinical Trials in Genitourinary Oncology.

Urology·2026

Positive surgical margins after robot-assisted radical prostatectomy Long-term oncologic consequences.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026

Early Termination of Phase II-III Genitourinary Oncology Trials: A Two-Decade Analysis of Causes and Trial-Level Risk Factors.

JCO oncology practice·2026

Limited progress in clinical trials for rare urologic cancers: Testicular and penile cancer.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026

Risk of second primary malignancies after bladder cancer diagnosed at a young age: a SEER population-based analysis.

International journal of clinical oncology·2026

Innovations in the management of urethral stricture disease: emerging and regenerative strategies.

The Canadian journal of urology·2026

Guideline-recommended post-operative intravesical chemotherapy and cystoscopic surveillance among patients with low- and intermediate-risk non-muscle invasive bladder cancer.

Bladder cancer (Amsterdam, Netherlands)·2026

Difficult conversations in bladder cancer survivorship: Integrating mental health and intimacy into routine urologic care.

Bladder cancer (Amsterdam, Netherlands)·2026

Intra- and extravesical recurrence after epirubicin-based hyperthermic intravesical chemotherapy (HIVEC) in patients with NMIBC and BCG failure: A multicenter retrospective Observational Study.

Bladder cancer (Amsterdam, Netherlands)·2026

Induction and characterization of neoplastic bladder tumors in a transgenic porcine model.

Bladder cancer (Amsterdam, Netherlands)·2026

Corrigendum to "The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial Tumors".

Bladder cancer (Amsterdam, Netherlands)·2026

Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis.

Bladder cancer (Amsterdam, Netherlands)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us